Nu Skin Enterprises, Inc.

NUS Consumer Defensive Household & Personal Products

Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.87 0.13 +2.74%
Market cap
$237.1M
P/E
0.0×
Fwd P/E
5.9×
Dividend yield
4.93%
F-score
7/9
Altman Z
3.78
Beneish M
−2.35
Dividend safety
70/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

14.55% 22.00% 7.04% (32.53%)
Piotroski F-Score
6 7 7 4
ROA
7.29% 11.15% 3.94% (16.87%)
ROIC
(0.85%) 5.21% 6.09% (1.15%)
Return on Tangible Assets
16.38% 24.23% 8.42% (34.27%)
Average Days of Receivables
11.44 9.72 11.40 12.98
Free Cash Flow per Share
1.08 0.93 0.86 0.22
Free Cash Flow
53.35 46.01 41.57 10.78
Capital Expenditures
(36.10) (34.28) (34.41) (40.03)
Other line items
Cash ROIC
4.16% 3.62% 3.41% 1.14%
Accounts Receivable Turnover
26.51 32.88 28.37 25.33
Accounts Payable Turnover
16.71 14.86 14.18 12.76
Inventory Turnover
2.40 2.46 2.41 2.28
Average Days of Payables
20.34 21.06 23.77 32.48
Days of Inventory on Hand
127.32 143.70 147.36 164.94
Tax Rate
(0.09) (0.18) (0.15) 7.20
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
63.33% 63.33% 63.65% 64.07%
Share Based Compensation of Revenue
1.56% 1.62% 1.28% 1.00%
Interest Coverage
(0.67) 4.71 5.34 (0.66)
Operating CF/Net income
0.82 0.50 1.39 (0.23)
Depreciation/Fixed assets
0.15 0.14 0.13 0.13
Capex/Depreciation
(0.65) (0.66) (0.68) (0.80)
Revenue per Share
31.59 30.13 29.90 28.30
Operating CF per Share
1.81 1.63 1.58 1.05
Capex per Share
(0.73) (0.70) (0.71) (0.82)
Capex to Sales
0.02 0.02 0.02 0.03

Fold the line items

Columns are period end dates